Vaccination programs in schools to improve access for underserved communities in Colorado
Official title: School-Located Vaccination to Reduce Inequities in Vaccination Uptake Among Historically Excluded Populations in Colorado
Funded at Rand Corporation · NIH-10942634 · Data updated 2026-11-12
This study is all about making it easier for kids under 11 in Colorado, especially those from communities that often face challenges, to get their COVID-19 vaccinations right at school, so they don’t have to worry about transportation or clinic hours.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project start | August 12, 2024 |
| Project end | June 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $582,465 |
| NIH project number | 1R01MD019798-01 |
| Project ID | NIH-10942634 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children aged 0-11 years from minoritized racial/ethnic groups or those living in underserved rural areas.
✕Less likely to help
Patients who are not within the age range of 0-11 years or those who have access to traditional healthcare services may not benefit from this research.
What this research studies
This research focuses on implementing school-located vaccination programs to address barriers faced by historically excluded populations in Colorado, particularly for children under 11 years old. By utilizing School-Based Health Centers and School-Located Vaccine Clinics, the project aims to provide easier access to COVID-19 vaccinations for students who may struggle to receive immunizations in traditional healthcare settings. The approach includes organizing vaccination events at schools, which can help overcome logistical challenges such as transportation and clinic hours. The study will evaluate the effectiveness of these programs in increasing vaccination rates among underserved communities.
Why it matters
Potential benefit: If successful, this research could significantly increase vaccination rates among children in underserved populations, thereby improving public health outcomes.
How similar studies have gone: Previous vaccination programs in schools have shown success in improving immunization rates, particularly during the H1N1 pandemic, indicating that this approach is both tested and effective.
Where this research is happening
-
Rand Corporation
Santa Monica, United States Active
Researchers
- Principal investigator: Gromis, Ashley — Rand Corporation
- Study coordinator: Gromis, Ashley
Related research
Other NIH-funded projects on the same topics.
-
Protective dengue vaccines that steer T and B cell responses
A vaccine study aims to guide the body’s T and B cells to fight all four dengue virus types safely and effectively.
-
Respiratory pathogen–specific T cell signatures after vaccination, infection, and treatment
A research effort to map how immune T cells respond to respiratory infections and vaccines, with potential to guide better vaccines and treatments for conditions like covid-19 and pertussis.
-
Malaria vaccine and infection: how the body’s early and later immune responses relate to protection
Researchers are studying how people’s immune systems respond to the malaria pre-erythrocytic stage, whether after vaccination or infection, to identify which responses are linked to protection.
-
Spatially responsive mass vaccination for urban rabies
A new plan uses data and maps to place vaccination sites where they’re most needed in cities, aiming to boost rabies vaccination for both people and dogs.
-
Spatially responsive mass vaccination for urban rabies
A project tests smarter placement of vaccination sites to increase mass canine rabies vaccination in cities.
-
Vaccine failure after Covid-19 vaccination in older adults
This project follows vaccinated older adults to understand who among them still gets Covid-19 and what factors make those outcomes worse.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.